NOTABLE EVENTS

Is the current R&D model of drug development likely to create - or destroy - value in the form of novel innovations that will serve patient needs of the future? What lessons have you learned from the development of your own nominated products that can be applied productively to introducing the next generation of breakthrough therapies?

Galien Golden Jubilee Webinar Series

Will progress in therapies that promise a genetic cure for devastating rare deseases lead to similar innovations in patient access to these high-cost, high-touch treatments?

Galien Golden Jubilee Webinar Series